Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on October 28, 2025, the repurchase of 100,000 of its Ordinary Shares at $1.7725 per share. These shares will be held in treasury. Following the transaction, the company's issued Ordinary Share capital is 345,967,440, with 18,743,791 shares held in treasury, leaving 327,223,649 total voting rights. The buyback was authorized at the Annual General Meeting in June 2025, permitting repurchases up to 14.99% of Ordinary Shares, and is valid until the next shareholder authority. The company intends to hold repurchased shares in treasury and has appointed Deutsche Numis as its broker for these transactions.

Disclaimer*

UK 100

Latest directors dealings